Showing posts with label asia. Show all posts
Showing posts with label asia. Show all posts

Wednesday, April 17, 2013

Enter ASEAN

The Far East has long captivated Western societies with philosophies and healing practices. Throughout history, trade was brisk along the spice routes, themselves considered a gateway of commerce, bringing treasures and wisdoms to Westerners who clamored for them and could afford them.

In the modern world, it seems, many of the Far Eastern peoples have become interested in emulating Western practices and consuming our products. And although many hold fast to their traditional medicinal systems (such as traditional Chinese medicine [TCM] in and around China), Western dietary supplements have made tremendous inroads, cultivating growing followings.

According to Reuel A. Igaña, an executive at FUDynamics International Inc., San Juan, Philippines, the total Asia Pacific nutritional supplement market in 2010 (excluding Japan, PROC and Australasia) was estimated to be worth US$11billion, and is expected to grow exponentially and quickly to US$28.5 billion by 2016. The southeast Asian health supplements industry is estimated to be worth more than US$2.5 to 3 billion, and the market is expected to grow at an annual rate of 10 percent each year.

"Similar to Americans, the affluent Asian consumers from Singapore, Malaysia, Thailand, Indonesia and Philippines are discerning consumers who appreciate products that are efficacious, safe and of premium quality," Igaña observed.

Interestingly, Igaña noted U.S.-made dietary supplement products are "perceived to be of good quality, with supporting testimonials and clinical data to substantiate claims. While the market is highly competitive and somewhat saturated, the best prospects include innovative supplements with scientifically proven benefits and focused on preventative care," he said.

The dynamics spurring the growth and strength of the Asian market again seem to mirror those in the United States: rising affluence, higher income and standard of living; the growing pursuit of healthier lifestyles, longer life expectancies; the sharply increased empowerment of women; and growth of young adults who consider themselves "trendy" as opposed traditional.

For more of the article, http://www.naturalproductsinsider.com/articles/2013/04/enter-asean.aspx





Sign up for DIA's Global SmartBrief: Break through the information clutter with FREE, twice-weekly email publication that gives quick, easy-to-read summaries of articles relevant to you. Get the latest news in drug development innovations worldwide wherever you are on your laptop or smart phone with SmartBrief’s wireless compatibility.

Wednesday, December 19, 2012

Fake Drugs Spurring Increase In Drug-Resistant Malaria.



The NPR (12/19, Beaubien) "Shots" blog reports, "Counterfeit drugs are a growing scourge around the world. They're generating millions of dollars in revenue for organized crime and fueling the rise of drug-resistant parasites. Anti-malarials are among the most popular drugs to fake," and they are "particularly dangerous because malaria can kill a person in a matter of days." Although some of the "fake drugs are nothing more than repackaged sugar pills or chalk," sometimes they "contain small amounts of anti-malarial drugs." That can cause a drug resistance "to develop," which is what "appears to be happening now in Southeast Asia with one of the most powerful anti-malarials, artemisinin."
 
DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191
 

Wednesday, December 12, 2012

Be a Part of Asia’s Most Innovative Regulatory Conference!


Asia Regulatory
Conference 2013
News & PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
 
OVERVIEW
Join health authority representatives and industry professionals from Asian and ICH member
countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.
 
OBJECTIVES
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
 
This conference will provide a forum to:
• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Day One – Research and Development
Day Two – Good Regulatory Practices
Day Three – 21st century Global Regulatory Challenges
Program
committee
chairs
Arun Mishra
Director
Global Regulatory Affairs
GlaxoSmithKline, UK
John C.W. Lim
Chief Executive Officer
Health Sciences Authority,
Singapore 
Who Should Attend
Are you a Representative of Health Authorities, a Regulatory Affairs professional, or a professional involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia? If so, then this conference is for you.
  • Ministries of Health and Medicines
  • Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development
  • Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)
To know more contact Ellen.Diegel@diahome.org.
SAVE THE DATE: 5th Annual Meeting DIA CHINA
2013 | May 12-15, 2013 | Beijing, China

Wednesday, November 28, 2012

Regulatory Convergence and Cooperation to Improve Access and Quality -Singapore


Asia Regulatory
Conference 2013
News & PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Regulatory Conference Program Now Available!
To kick off 2013, the Asia Regulatory Conference is bringing together global regulatory professionals to share past experiences and new practices. Don’t miss this exciting event to interact with regulatory and other professionals!
OVERVIEW
Join health authority representatives and industry professionals from Asian and ICH member
countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.
OBJECTIVES
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
This conference will provide a forum to:
• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Day One – Research and Development
Day Two – Good Regulatory Practices
Day Three – 21st century Global Regulatory Challenges
Program
committee
chairs
Arun Mishra
Director
Global Regulatory Affairs
GlaxoSmithKline, UK
John C.W. Lim
Chief Executive Officer
Health Sciences Authority,
Singapore 
Who Should Attend
Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
  • Ministries of Health and Medicines
  • Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development
  • Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)
To know more contact Ellen.Diegel@diahome.org.
SAVE THE DATE: 5th Annual Meeting DIA CHINA
2013 | May 12-15, 2013 | Beijing, China

Sunday, November 11, 2012

Patient Safety: A Sustained Focus from Scientific Ideas to Innovative Medicines - 5th DIA China Annual Meeting - May 12-15, 2013 - Beijing


News & PublicationsMeetings &
TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Hot Topics and Sessions at 5th DIA China
2013 Annual Meeting
This year’s theme “Patient Safety: A Sustained Focus from Scientific Ideas to Innovative Medicines”  will reinforce patient safety as a core element of therapeutic innovation and a key philosophy throughout the life cycle of biopharmaceutical R&D.
5th DIA China 2013 Annual Meeting will be held on May 12-15, 2013 at the Beijing International Convention Center in Beijing. It is expected to attract over 1200 professional participants, spotlighted with plenary and parallel sessions, including pre-conference workshops, forums, speakers and presentations, panel discussions, call for abstracts & posters, exhibitions, networking receptions, and more.
5th DIA China 2013 Annual Meeting is the largest annual meeting held by DIA in Asia & Pacific region, providing a neutral platform for information exchange, featuring speakers that include high-level representatives from government, industry and academics in China and abroad. In 2012, the 4th DIA China Annual Meeting attracted over 1170 participants from all sectors, including multi-national pharma, local pharma, CRO, bio-pharma, regulatory agencies, academic institutes, and clinical sites.
NEW subject matter and hot topics include:
  • China drug safety monitoring system and update
  • Medical devices and combinational drugs
  • Oncology drug research - demands and challenges
  • Over the counter drug development in China
  • Pharmacoepidemiology
  • Risk benefits
  • Traditional Chinese Medicines - regulations and patient benefits
Don’t miss the region’s biggest meeting for pharmaceutical and medical product professionals to seek the most-up-to-date information and innovative tools you need to get ahead, especially within patients and their safety. DIA China cordially invites you to join us for the 5th DIA China 2013 Annual Meeting!
Co-Sponsored By: 
China Center for Pharmaceutical International Exchange (CCPIE)
CONTACT INFORMATION
Conference:

Runshan CHEN:
ting.chen@diachina.org
Fei XIE: fei.xie@diachina.org
Tel: +86.10.6260.2240
Exhibtion, advertisement, hosting:
Jean XU:
jxu@kellencompany.com
Tel: +86.10.5923.1096

Sofie PEETERS:
speeters@kellencompany.com
Tel: +86.159.1093.4696


DIA中国办公室 (DIA CHINA OFFICE)
中国北京海淀区中关村西区海淀东三街2号,欧美汇大厦七层766室,邮编100080
7/F, Room 766, Metropolis Tower, No.2 Haidian East Third Street, Zhongguancun
Xi Zone, Haidian District, Beijing, 100080, China
Tel: +86.10.6260.2240         Fax: +86.10.6260.2201

Email:
dia@diachina.org        Web: www.diachina.org

Tuesday, November 6, 2012

Asia Regulatory Conference 2013 - Jan 28-30, Singapore

Asia Regulatory Conference 2013

Jan 28 2013 7:00AM - Jan 30 2013 5:00PM | Raffles City Convention Centre 252 North Bridge Road Singapore 179103 Singapore

Overview

Join health authority representatives and industry professionals from Asian and ICH member countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.

Who Should Attend

Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
In particular professionals involved in:
  • Ministries of Health and Medicines Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)

Learning Objectives

This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines. This conference will provide a forum to:
  • Facilitate discussion on common issues in the regulatory and technical areas in Asia
  • Encourage greater convergence of regulatory requirements in Asia
  • Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Conference speakers will include top-level regulatory authorities from several Asian countries as well as leading experts in the ICH process. In addition, speakers will include representatives of WHO, various regulatory agencies from other regions and the multinational and local pharmaceutical industry.

<< link to program >>

 

Friday, October 26, 2012

Upcoming Life Sciences/Professional Development opportunites with DIA- India, Canada, Japan, and Singapore


From DIA
Upcoming DIA Meetings:
INDIA
Final Days to Register!
DIA India 7th Annual Meeting
November 1-4 | Hyderabad
With 2 Tutorials: Bioinformatics and Personalized Medicine
Join colleagues in new avenues in clinical operations, data management, highlighting systems biology paradigm as well as networking with the largest gathering of International and Indian Regulators and Industry professionals in India.

On Twitter: #DIAIndiaAM2012
To exhibit & showcase your products and services call +91.98.1977.7493
NORTH AMERICA:
DIA’s Annual Canadian Meeting: Evolutions in Risk Thinking
November 6-7 | Ottawa
This meeting will explore the challenges that industry, regulators, policy makers and those involved in health product lifecycle face in understanding and defining acceptable levels of risk across disciplines and through the drug development and lifecycle management.
JAPAN:
9th DIA Japan Annual Meeting

November 19-21 | Tokyo, Japan
Patient safety will be the primary focus in this year’s meeting; our key words will be “Patient Benefit.” We will expand the scope of our meeting to cover global development with a special 3-day, 6-track workshop.
1st Clinical Operation & Monitoring Workshop in Japan
January 24-25 | Tokyo, Japan
This workshop is a first in clinical operations and monitoring. Better reach your colleagues and gain new perspectives on industry challenges. Don't miss interactive sessions and networking, too.
Save the Date for DIA's 2013 Meetings
Asia Regulatory Conference 2013
January 28-30, 2013 | Singapore
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.  
16th Annual Workshop in Japan for Clinical Data Management: SMART CDM
February 7-8 | Tokyo, Japan
This meeting focuses on SMART CDM, to further teach all attendees, from beginners to experts, to take advantage of sophisticated technology and information, provide new perspectives on international clinical data management and create better solutions for smarter CDM, as well as opportunities to network with colleagues in global Clinical Data Management.

Wednesday, October 17, 2012

Importance of Development Strategies for Life Cycle Management of Safe and Effective Medical Products -> 9th DIA Japan Annual Meeting


9th DIA Japan Annual Meeting | Importance of Development Strategies for Life Cycle Management of Safe and Effective Medical Products | November
19-21, 2012 | Tokyo, Japan

Don’t Miss this Highly Anticipated Event and Register Today.
Informative tutorials, networking with colleagues and informative exhibits, impressive keynote speakers, and registration savings- all crucial elements to a successful meeting. Find them all at the 9th DIA Japan Annual Meeting, with focus on creating new solutions to the life cycle management of safe and effective medical products.
UPCOMING EVENTS
Asia Regluatory Conference 2013 | January 28-30, 2013 | Singapore
Conference Keynote Speakers and Tutorials
Keynote Speaker 1: Peter Bachmann, DrSc
European and International Affairs Member of the CMDh
(Co-ordination Group for Mutual Recognition and
Decentralised Procedures - Human) on the Latest Regulatory Environment in EU - from Development to Post-Marketing.

Keynote Speech 2: Takao Yamori, PhD
Director of Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency (PMDA) to discuss the New Drug Development of Japan Origin through Industry-Academia Collaboration.
Tutorials:
Tutorial 1: Company Core Data Sheets Prepared by Western Companies
Tutorial 2: Roundtable Discussion: What are Preferable Skill Sets in Clinical Development
Tutorial 3: Group Work: Action Learning for Six Sig
Tutorial 4: Risk Management Plan - Standard (As of 10/30/2012)
Tutorial 5: Leadership and Philosophy: Best Practice
Tutorial 6: Basic Understanding of Bioequivalence

Monday, October 15, 2012

Indonesia Issues Decree To Override Patents On HIV Medicines.

Reuters (10/12, Bigg) reported that Indonesia's government is acting to override patents on HIV medications. The move highlights a trend by Asian nations to allow local production of cheap generic medicine. Last month, President Susilo Bambang Yudhoyono issued a decree authorizing government use of patents for seven hepatitis B and HIV/AIDS medicines held by companies, including GlaxoSmithKline, Merck & Co, Bristol-Myers Squibb, Gilead, and Abbott. The decree said the government implemented the measures to "meet the urgent need for antiviral and antiretroviral treatments." The international trade association, which represents major pharmaceutical companies said the move set "a negative precedent."


from DIA Daily
DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.
View BulletinHealthcare's privacy policy.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare | 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191

Monday, October 8, 2012

Regulatory Convergence and Cooperation to Improve Access and Quality - AsiaReg2013


Asia Regulatory Conference 2013
News &
PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Regulatory Conference Registration Now Available!
To kick off 2013, the Asia Regulatory Conference is bringing together global regulatory professionals to share past experiences and new practices. Don’t miss this exciting event to interact with regulatory and other professionals!
OVERVIEW
Join health authority representatives and industry professionals from Asian and ICH member
countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.
OBJECTIVES
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
This conference will provide a forum to:
• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Day One – Research and Development
Day Two – Good Regulatory Practices
Day Three – 21st century Global Regulatory Challenges
Program
committee
chairs
Arun Mishra
Director
Global Regulatory Affairs
GlaxoSmithKline, UK
John C.W. Lim
Chief Executive Officer
Health Sciences Authority,
Singapore 
Who Should Attend
Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
  • Ministries of Health and Medicines
  • Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development
  • Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)
To know more contact Ellen.Diegel@diahome.org.